financetom
Business
financetom
/
Business
/
Tesla's Q3 Results Likely In-Line With Slight Margin Upside, Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla's Q3 Results Likely In-Line With Slight Margin Upside, Wedbush Says
Oct 21, 2024 7:38 PM

11:55 AM EDT, 10/21/2024 (MT Newswires) -- Tesla (TSLA) Q3 results are expected to meet analysts' expectations, with slight margin improvements, Wedbush said in an earnings preview Monday.

Investors will likely focus on Tesla Chief Executive Elon Musk's comments on the demand for consumer electric vehicles heading into Q4 and 2025 when the company reports its Q3 earnings Wednesday, Wedbush said. With in-line deliveries in Q3, Tesla's target of 1.8 million units for 2024 remains achievable, with a focus on surpassing 2 million units in 2025, the firm added.

The firm said it expects that the company's margins will be under scrutiny as the market seeks to confirm margin stabilization and recovery.

Strong sales in China during Q3 are expected to drive Q4 performance as well, the firm said. Still, the company faces challenges in Europe due to macroeconomic pressures and reduced subsidies, though these may be balanced by demand stabilization in the US and other regions.

"There are a lot of moving parts in the Tesla story over the next year but ultimately the encouraging China strength seen this quarter will be a linchpin for the bullish Tesla narrative looking ahead while the AI strategy evolves," analysts said in the note.

The firm maintained Tesla's outperform rating and $300 price target.

Price: 218.19, Change: -2.51, Percent Change: -1.14

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Veralto Q1 Adjusted Earnings, Sales Rise; Q2 Guidance Set
Veralto Q1 Adjusted Earnings, Sales Rise; Q2 Guidance Set
Apr 28, 2026
04:56 PM EDT, 04/28/2026 (MT Newswires) -- Veralto ( VLTO ) reported Q1 adjusted earnings late Tuesday of $1.07 per diluted share, up from $0.95 a year earlier. Analysts polled by FactSet expected $1. Sales for the three months ended April 3 were $1.42 billion, up from $1.33 billion a year earlier. Analysts surveyed by FactSet expected $1.40 billion. For...
Constellation Brands Insider Sold Shares Worth $307,830, According to a Recent SEC Filing
Constellation Brands Insider Sold Shares Worth $307,830, According to a Recent SEC Filing
Apr 28, 2026
04:56 PM EDT, 04/28/2026 (MT Newswires) -- Ernesto M Hernandez, Director, on April 27, 2026, sold 2,000 shares in Constellation Brands ( STZ ) for $307,830. Following the Form 4 filing with the SEC, Hernandez has control over a total of 2,582 Class A common shares of the company, with 2,582 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/16918/000161435726000002/xslF345X05/wk-form4_1777409663.xml ...
STAG Industrial Q1 Core FFO, Revenue Rise
STAG Industrial Q1 Core FFO, Revenue Rise
Apr 28, 2026
04:57 PM EDT, 04/28/2026 (MT Newswires) -- STAG Industrial ( STAG ) reported Q1 core funds from operations late Tuesday of $0.65 per diluted share, up from $0.61 a year earlier. Analysts polled by FactSet expected $0.64. Total revenue for the three months ended March 31 was $224.2 million, up from $205.6 million a year earlier. Analysts surveyed by FactSet...
Health Canada approves first generic version of Novo Nordisk's Ozempic
Health Canada approves first generic version of Novo Nordisk's Ozempic
Apr 28, 2026
April 28 (Reuters) - Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's blockbuster diabetes drug Ozempic made by Indian drugmaker Dr Reddy's Laboratories, its website showed on Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved